Difference between revisions of "Red Pill"
Jump to navigation
Jump to search
Line 183: | Line 183: | ||
|- | |- | ||
|align="left"| | |align="left"| | ||
− | * Has vagina | + | * Has [[vagina]] |
− | * Femininity less than <span title="70">85%</span> | + | * [[Femininity]] less than <span title="70">85%</span> |
+ | * 33% Chance | ||
|align="left"| | |align="left"| | ||
− | * | + | * Increase [[femininity]] by <span title="10">5%</span>-<span title="14">7%</span> |
|- | |- | ||
|align="left"| | |align="left"| | ||
− | * Has vagina | + | * Has [[vagina]] |
− | * | + | * Biggest [[chest|breast]] size at C-cup or more |
− | * Cannot lactate | + | * Cannot [[milk|lactate]] |
+ | * 20% Chance | ||
|align="left"| | |align="left"| | ||
− | * | + | * [[Milk#Milk Multiplier|Milk Multiplier]] becomes 60 |
|- | |- | ||
|align="left"| | |align="left"| | ||
− | * Libido less than 60 | + | * [[Libido]] less than 60 |
+ | * 33% Chance | ||
|align="left"| | |align="left"| | ||
* 1/3 chance to have a [[Combat_Mechanics_#Slow_Stat_Gain|slow libido gain]] of 5 | * 1/3 chance to have a [[Combat_Mechanics_#Slow_Stat_Gain|slow libido gain]] of 5 |
Revision as of 10:35, 7 July 2019
Red Pill | |
---|---|
Type | Drug, Pill |
Base Price | 600 |
Information | |
Usable | Yes |
Defensive Target | Self |
A simple-looking pill with white and red stripes produced by Xenogen Biotech, this pill is loaded with a new, proprietary blend of nanomachines programmed to rebuild your body in the image of a red myrmedion, one of the ant-like inhabitants of Myrellion.
A Xenogen-brand product.
Acquisition
After successfully completing Nevrie's coworker quest and visiting Dr. McAllister to finish his myr experimentation, this item will be available for purchase from Nevrie at the Xenogen Biotech Outpost on Myrellion.
Usage
This item will be consumed on use. In doing so, the pill will have immediate permanent effects on the player character, with up to five possible mutations total, or none at all.
Condition | Change |
---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|